Individuell angepasste Diagnostik und Therapie

Strik H, Prommel P. Diagnosis and individualized therapy of neoplastic meningitis. Expert Rev Anticancer Ther. 2010;10(7):1137–48.

Glass JP et al. Malignant cells in cerebrospinal fluid (CSF): the meaning of a positive CSF cytology. Neurology. 1979;29(10):1369–75.

Chamberlain MC. Neoplastic meningitis. J Clin Oncol. 2005;23(15):3605–13.

DeAngelis LM, Boutros D. Leptomeningeal metastasis. Cancer Invest. 2005;23(2):145–54.

Gleissner B et al. Therapie der Meningeosis Neoplastica. Journal Onkologie. 2005;(4):40–5.

Gokbuget N, Hoelzer D. Meningeosis leukaemica in adult acute lymphoblastic leukaemia. J Neurooncol. 1998;38(2–3):167–80.

Strik HM et al. A case of spinal glioblastoma multiforme: immunohistochemical study and review of the literature. J Neurooncol. 2000;50(3):239–43.

Balm M, Hammack J. Leptomeningeal carcinomatosis. Presenting features and prognostic factors. Arch Neurol. 1996;53(7):626–32.

Wasserstrom WR et al. Diagnosis and treatment of leptomeningeal metastases from solid tumors: experience with 90 patients. Cancer. 1982;49(4):759–72.

Herrlinger U et al. Meningeosis neoplastica im Rahmen einer ZNS-Metastasierung. Onkologe. 2008;14(3):267–73.

Chamberlain MC, Kormanik PA. Prognostic significance of 111indium-DTPA CSF flow studies in leptomeningeal metastases. Neurology. 1996;46(6):1674–7.

Prömmel P et al. Neoplastic meningitis: How MRI and CSF cytology are influenced by CSF cell count and tumor type. ScientificWorldJournal. 2013;2013:248072.

Freilich RJ et al. Neuroimaging and cerebrospinal fluid cytology in the diagnosis of leptomeningeal metastasis. Ann Neurol. 1995;38(1):51–7.

Heller T et al. Automated cerebrospinal fluid cytology. Anal Quant Cytol Histol. 2008;30(3):139–44.

Strik H et al. Automated cerebrospinal fluid cytology: limitations and reasonable applications. Anal Quant Cytol Histol. 2005;27(3):167–73.

Moldrich G et al. Carcinoembryonic antigen in the CSF of cancer patients—the value of intrathecal synthesis and correlation with IgA-diffusion dynamics. Acta Neurol Belg. 2010;110(4):314–20.

Kolodziej MA et al. Cerebrospinal fluid ferritin—unspecific and unsuitable for disease monitoring. Neurol Neurochir Pol. 2014;48(2):116–21.

DeAngelis LM. Current diagnosis and treatment of leptomeningeal metastasis. J Neurooncol. 1998;38(2–3):245–52.

Hoffmann A et al. Neoplastic meningitis from breast cancer: feasibility and activity of long-term intrathecal liposomal Ara-C with dose-dense temozolomide. Anticancer Res. 2009;29(2):5191–5.

Boogerd W et al. Meningeal carcinomatosis in breast cancer. Prognostic factors and influence of treatment. Cancer. 1991;67(6):1685–95.

Hughes EN et al. Medulloblastoma at the joint center for radiation therapy between 1968 and 1984. The influence of radiation dose on the patterns of failure and survival. Cancer. 1988;61(10):1992–8.

Choong NW et al. Gefitinib response of erlotinib-refractory lung cancer involving meninges—role of EGFR mutation. Nat Clin Pract Oncol. 2006;3(1):50–7.

Sakai M et al. Carcinomatous meningitis from non-small-cell lung cancer responding to gefitinib. Int J Clin Oncol. 2006;11(3):243–5.

Shepherd DA et al. Accidental intrathecal administration of vincristine. Med Pediatr Oncol. 1978;5(1):85–8.

Rubenstein JL et al. Rituximab therapy for CNS lymphomas: targeting the leptomeningeal compartment. Blood. 2003;101(2):466–8.

Glantz MJ et al. Route of intracerebrospinal fluid chemotherapy administration and efficacy of therapy in neoplastic meningitis. Cancer. 2010;116(8):1947–52.

Chamberlain MC et al. Treatment of leptomeningeal metastasis with intraventricular administration of depot cytarabine (DTC 101). A phase I study. Arch Neurol. 1993;50(3):261–4.

Weller M et al. S2k-Leitlinie „Metastasen und Meningeosis neoplastica“. Deutsche Gesellschaft für Neurologie. 2014; www.dgn.org/leitlinien/11-leitlinien-der-dgn/2979-ll-77-metastasen-und-meningeos-neoplastica . Abgerufen am 30.04.2015.